Changes of the effect site concentration and bispectral index in different sedation levels in patients undergoing target-controlled infusion of remimazolam
Not Applicable
Not yet recruiting
- Conditions
- Not Applicable
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
1. Patients who were scheduled for elective surgery under general anaesthesia
2. Patient who with American Society of Anesthesiologists grades I-III
3. Patients with aged 20-75 year
4. Patients who voluntarily agreed to be enrolled to the clinical research and signed written informed consent
Exclusion Criteria
1. Patients who has cardiovascular disease (arrthymia, ischemic heart disease, myocardical infarction, heart failure)
2. Patients who has neurovascular disease
3. Patients who has a history of drug use that could affect the central nervous system
4. Patients who has a history of adverse reactions to anesthetic agents
5. Pregnant female, or female who breast-feeds her baby
6. Other in-appropriative patients under the researcher's decision.
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method sedation level score using Modified Observer’s Assessment of Alertness/Sedation (MOAA/S); (1== does not respond to mild prodding or shaking; 2 = responds only after mild prodding or shaking; 3 = responds only after name is called loudly or repeatedly; 4 = lethargic response to name spoken in normal tone; 5 = responds readily to name spoken in normal tone)
- Secondary Outcome Measures
Name Time Method bispectral index